In addition to peripheral nervous system and rash involvement, the expression of CXCL9 was noticeably higher in pSS patients with joint, blood, kidney, and ILD involvement in comparison to pSS-non-EGM patients. This evidence concerns the gene CXCL9 and peeling skin syndrome.